Briakinumab Biosimilar(Anti-IL-12 (IL-12a & IL-12b) Reference Antibody) Datasheet DC Chemicals
Description Briakinumab (ABT-874) is a fully human anti-IL-12/23p40 monoclonal antibody. Briakinumab targets and neutralizes IL-12 and IL-23. Briakinumab can be used for the research of rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis.
Cat.No A290
Name Briakinumab Biosimilar(Anti-IL-12 (IL-12a & IL-12b) Reference Antibody)

Chemical Properties

CAS 339308-60-0
Synonyms Briakinumab;A 796874.0;ABT 874;BSF 415977;J 695;LU 415977;WAY 165772;Research Grade Briakinumab
pH value Corresponds to reference standard: PASS
Non-reduced CE-SDS >95%
SEC-HPLC >95%
Isoelectric Point Corresponds to reference standard
Bacterial Endotoxins Test
Residual Proteins of Host Cell
Exogenous Residual DNA
Residual protein A
Biological Activity
Osmolality Corresponds to reference standard: PASS
Peptide mapping Corresponds to reference standard: PASS
N-terminal sequence Corresponds to reference standard: PASS

References

Return Policy
If you are in any way unsatisfied with your purchase, you may return any item(s) within 365 days of its original purchase date.
Please provide your Order Number in the email. We strive to reply to all email inquiries within one business day.
Tel: +86-21-58447131
Fax: +86-21-61642470

Email:
sales@dcchemicals.com
order@dcchemicals.com

Website:
www.dcchemicals.com